Inventiva SA header image

Inventiva SA

IVA

Equity

ISIN FR0013233012 / Valor 35598121

Euronext - Euronext Paris (2026-06-11)

EUR 3.31+1.85%

Inventiva SA
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Inventiva SA is a clinical-stage biopharmaceutical company based in France, publicly traded on Euronext, that discovers and develops oral small-molecule therapies aimed primarily at liver, fibrotic and metabolic diseases and certain rare genetic disorders. Its most advanced program is lanifibranor (IVA337), a pan-PPAR agonist being developed as a treatment for non-alcoholic steatohepatitis (NASH), and the company also pursues drug candidates for lysosomal storage and muscle-related conditions. Inventiva advances compounds through preclinical and clinical studies and seeks collaborations and licensing arrangements to support development and potential commercialization.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

12.6%1Y

5.08%3Y

-73.3%5Y

Performance

58.0%1Y

64.0%3Y

61.3%5Y

Volatility

796 M

Market cap (USD)

340,113

Daily traded volume (Shares)

/

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A. Valor: 2791431

Annual Return

-50%0%+50%

Risk level

110

-0.33%CHF 12.06

UCB SA

UCB SA Valor: 986410

Annual Return

-50%0%+50%

Risk level

110

1.44%EUR 274.90

agilon health inc

agilon health inc Valor: 110653729

Annual Return

-50%0%+50%

Risk level

110

-2.80%USD 112.91

Laboratorios Farmaceuticos Rovi, SA

Laboratorios Farmaceuticos Rovi, SA Valor: 3591807

Annual Return

-50%0%+50%

Risk level

110

1.29%EUR 58.80

Almirall SA

Almirall SA Valor: 3180354

Annual Return

-50%0%+50%

Risk level

110

1.25%EUR 11.34

Sienna Senior Living Inc

Sienna Senior Living Inc Valor: 28093100

Annual Return

-50%0%+50%

Risk level

110

0.09%CAD 21.47

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc Valor: 33395434

Annual Return

-50%0%+50%

Risk level

110

1.37%USD 480.77

HealthEquity Inc

HealthEquity Inc Valor: 24679014

Annual Return

-50%0%+50%

Risk level

110

-0.70%USD 88.34

Alkermes PLC

Alkermes PLC Valor: 13920929

Annual Return

-50%0%+50%

Risk level

110

-1.42%USD 44.28

Denali Therapeutics Inc

Denali Therapeutics Inc Valor: 39149539

Annual Return

-50%0%+50%

Risk level

110

3.04%USD 21.66

SIX

FactSet

Clearbit

Logos provided by Clearbit